Kura Oncology Files 8-K
Ticker: KURA · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1422143
| Field | Detail |
|---|---|
| Company | Kura Oncology, INC. (KURA) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financial-statements
TL;DR
Kura Oncology filed an 8-K on June 3rd, reporting events as of June 1st. Details TBD.
AI Summary
Kura Oncology, Inc. filed an 8-K on June 3, 2025, reporting other events and financial statements as of June 1, 2025. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates a significant corporate event or financial update for Kura Oncology, Inc., requiring disclosure to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no immediate negative or positive indicators in the provided text.
Key Players & Entities
- Kura Oncology, Inc. (company) — Registrant
- June 1, 2025 (date) — Date of earliest event reported
- June 3, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- San Diego, CA (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Kura Oncology, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.
What is the significance of the 'Financial Statements and Exhibits' being filed?
The filing indicates that financial statements and exhibits are being submitted, but the specific content or period they cover beyond the report date is not detailed in the provided excerpt.
What was Kura Oncology, Inc.'s former name?
Kura Oncology, Inc.'s former name was ZETA ACQUISITION CORP III, with a date of name change on December 27, 2007.
What is Kura Oncology, Inc.'s principal executive office address?
Kura Oncology, Inc.'s principal executive office is located at 12730 High Bluff Drive, Suite 400, San Diego, CA 92130.
What is the SEC Act and File Number associated with this filing?
This filing is made pursuant to the 1934 Act and has the SEC File Number 001-37620.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Kura Oncology, Inc. (KURA).